https://www.medscape.com/viewarticle/987702
0
0
1/31/23 at 3:04pm
Organization
Medscape
45 words
0
Comments
Among adults with type 2 diabetes and an eGFR < 30 mL/min/1.73m2, treatment with a GLP-1 agonist was associated with better renal preservation and survival compared with a DPP-4 inhibitor.
You are the first to view
Create an account
or login to join the discussion